Expression of Cyclin D1 protein in residual tumor after neoadjuvant chemotherapy for breast cancer

Villegas, SL; Darb-Esfahani, S; von Minckwitz, G; Huober, J; Weber, K; Marme, F; Furlanetto, J; Schem, C; Pfitzner, BM; Lederer, B; Engels, K; Kummel, S; Muller, V; Mehta, K; Denkert, C; Loibl, S

Denkert, C (reprint author), Charite Univ Med Berlin, Inst Pathol, Charitepl 1, D-10117 Berlin, Germany.; Denkert, C (reprint author), German Canc Consortium DKTK, Partner Site Charite, Berlin, Germany.

BREAST CANCER RESEARCH AND TREATMENT, 2018; 168 (1): 179

Abstract

Hormone receptor (HR)-positive breast cancer (BC) shows a poor response to neoadjuvant chemotherapy (NACT). New treatment targets like the Cyclin D1-C......

Full Text Link